Mail Sport's racing expert Robin Goodfellow delivers his tips for Saturday's meetings at Southwell, Newcastle, Ascot, Wincanton and Haydock. Southwell Robin Goodfellow 4.05 Jesse Luc 4.40 Blue ...
DOC Pharma strengthens its offerings with the acquisition of the Geopharma nutraceuticals portfolio, and the closing of the previously announced acquisition of Muscoril® New brand identity ...
In a report released on February 14, Christophe dombu from Kepler Capital maintained a Buy rating on Hyloris Pharmaceuticals SA (52U – Research Report), with a price target of €16.00.
The Company had approximately $98.8 million in cash and cash equivalents as of December 31, 2024. Net cash used in operating activities was approximately $60.9 million, compared to $102.0 million ...
The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...
As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.
The mouse on the right with four times the normal muscle mass is placed with a normal mouse. Handout via REUTERS About a dozen drugmakers are developing new weight-loss treatments aimed at ...
Perform material- and labor-effective extrusion with Thermo Scientificâ„¢ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...
On Tuesday, Recursion Pharmaceuticals stock reached a key performance benchmark, with its Relative Strength (RS) Rating rising into the 90-plus percentile with an improvement to 92, a rise from 64 ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
1 Day ELTP 0.00% DJIA -0.26% Russell 2K 0.25% Health Care/Life Sciences 0.00% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus vaccine in a case with ties to U.S. Department of Health and Human ...